Speaker

Dr Hari Kuhan completed his undergraduate medical training at Imperial College London, where he also obtained a BSc in Surgery and Anaesthesia. He carried out his foundation and core medical training in Central London, with appointments at St Mary's Hospital and St Bartholomew's Hospital. Over time, he built substantial expertise in Medical Oncology, working at leading institutions including St Bartholomew's, University College London, and the Royal Marsden Hospital.

He then pursued a research fellowship at Barts Cancer Institute, London funded by Stand Up to Cancer and HCA Healthcare, focusing on metabolic vulnerabilities in cancer stem cells and circulating tumour cells through the use of repurposed medicines and Vitamin C. Expanding his reach into translational and clinical development, Dr Kuhan joined the Sarah Cannon Research Institute UK (Harley Street), London where he served as lead sub-investigator on multiple Phase I and II solid tumour trials, and became adept at integrating next-generation sequencing outputs into therapeutic decision-making.

Motivated by both scientific innovation and patient-centred care, Dr. Kuhan co-founded Lucio Health with long-time associate Raphael Swery, united by a vision to reshape cancer care for the 21st century. Together, they established a clinic that integrates precision oncology, metabolic targeting, repurposed medicines, and evidence-based integrative strategies-pioneering a personalised model that moves beyond the limitations of conventional, one-size-fits-all approaches.

At Lucio Health, cutting-edge AI-driven platforms interpret complex mutational and molecular data, while functional sensitivity testing of blood and tissue samples reveals how an individual's cancer responds to a wide range of agents in real time. These insights are then integrated with metabolic and genomic profiling to create multi-layered, personalised roadmaps for each patient-designed not only to identify the most promising treatments, but also to avoid those unlikely to help.

Dr Hari Kuhan will be speaking in the Integrative Oncology Conference taking place on Friday 19th June 2026. The full conference programmes will be announced in February 2026.

Dr Kuhan is the co-author of the book Metabolic Drugs for Cancer, with Amanda King, ND

Click here to buy Metabolic Drugs for Cancer